Technicals

3 Reasons Why Antero Midstream (AAPL) is a Great Momentum Stock

Many investors like to look for momentum in stocks, but this can be very tough to define. There is great debate regarding which metrics are the best to focus on in this regard, and which are not really quality indicators of future performance. Fortunately, with our new style score system we have identified the key statistics to pay close attention to and thus which stocks might be the best for momentum investors in the near term. […]

Stock Analysts

5 Strong Buy Liquid Stocks for 2017

Adopting a strategy that has the potential to yield impressive returns during any market conditions might be a great way to start 2017. One may build a portfolio of stocks with favorable liquidity to achieve the above objective. […]

Stock Analysts

Will Goldman and JPMorgan Dominate Once Again in 2017?

It has been a roller coaster ride for finance sector stocks in 2016. The year begun on a pessimistic note as slump in oil prices, low client activity, Brexit-related concerns and slowdown in China significantly hurt the financials. Nonetheless, the sector showed resilience and as the year progressed, these concerns gradually eased […]

Stock Analysts

Monmouth Buys Fort Myers Building, Asset Tally Reaches 100

Monmouth Real Estate Investment Corporation MNR has shelled out $21.0 million for the acquisition of a new industrial building in Fort Myers, FL. With this acquisition, the company’s tally of owned properties reached 100, which are strategically positioned across 30 states. Net-leased for 10 years to FedEx Ground Packaging System, this 213,672 square foot building placed on around 22.49 acres in the vicinity of the Southwest Florida International Airport seems a solid buy. […]

Stock Analysts

MKS Instruments Up to Strong Buy on Solid Growth Drivers

On Jan 2, 2017, we issued an updated research report on premium technology company MKS Instruments, Inc. MKSI . Post release of robust third-quarter 2016 (Oct 26, 2016) results, this Zacks Rank #1 (Strong Buy) company’s shares recorded a return of 21.60% – outperforming 12.90% returns provided by the Zacks categorized Electronic Manufacturing-Machinery industry. […]

Stock Analysts

3 Overlooked Drug Stocks to Watch Out for in 2017

2016 was a rough year for the medical sector especially biotech stocks with the NASDAQ Biotechnology index declining 19.1% during the year while the NYSE ARCA Pharmaceutical Index was down 9.7%. The pharma/biotech sector faced several headwinds last year including slow product launches, fewer drug approvals, pipeline setbacks and increasing competition including the presence of biosimilars. […]